08:57 GOLDEN MEDITECH<08180> - Quarterly Results Announcement (2) 2.2 Basic earnings per share The calculation of basic earnings per share for the nine months ended 31 December 2004 is based on the unaudited consolidated profit attributable to shareholders of HK$104,225,000 (2003: HK$75,176,000) divided by the weighted average number of 1,196,850,086 (2003: 1,004,837,346 restated) shares in issue during the period. The weighted average number of shares has been restated to reflect the Bonus Issue as if it were effected during the period. 2.3 Diluted earnings per share The calculation of diluted earnings per share for the nine months ended 31 December 2004 is based on the unaudited adjusted profit attributable to shareholders of HK$104,881,000 (2003: HK$75,176,000) which is the profit attributable to shareholders for the period adjusted for the accrued interest expense related to the convertible bond of HK$656,000 divided by the weighted average number of 1,256,571,707 (2003: 1,018,947,210 restated) shares in issue during the period after adjusting for the effects of all dilutive potential shares. The weighted average number of shares has been restated to reflect the Bonus Issue as if it were effected during the period. 3 Convertible bond A principal amount of HK$124,000,000 remains oustanding as at 31 December 2004 under the convertible bond issued by the Company on 6 September 2004. The convertible bond bears interest at the rate of 1% per annum and will mature in three years subsequent to the date of issue. The outstanding principal amount of the convertible bond may be converted into ordianry shares of the Company at an initial conversion price of HK$3.8 per share, subject to adjustment at any time and from time to time, after three months subsequent to its date of issue. As a result of the Bonus Issue, the conversion price has been adjusted to HK1.9 per share, with effect from 24 September 2004, in accordance with the terms of the convertible bond. 4 Share option exercise price As a result of the Bonus Issue, the exercise price of the outstanding share options pursuant to the terms of the share option scheme adopted by the Company on 30 July 2002 has been adjusted from HK$1.15 per share to HK$0.575 per share, with effect from 24 September 2004.